LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Mike English New President of Innovasis
People In The News

Mike English New President of Innovasis

March 2, 2017 1 min read Premium comments

Advertisement

Mike English New President of Innovasis
Mike English
#innovasis#mikehelm

Mike English has taken the helm at Innovasis, Inc., makers of spine and cranial implants based in Salt Lake City, Utah. English, who joined the company in 2014, most recently served as its Executive Vice President.

“I’m honored to have the opportunity to lead this extraordinary team. Our positive cash position and strong revenue growth will allow us to continue investing in innovation and talent,” said English in the February 17, 2017 news release.

“He brings over 20 years of executive leadership experience in medical device and spine including Johnson & Johnson and NuVasive,” says the news release. “Innovasis posted significant growth in 2016 while introducing the Excella-MIS system and the PX HA PLIF cage to the market. They are positioned to launch several new products in 2017 and plan to continue building their executive team.”

Mike English told OTW, “We are focused on hiring key personnel to support our rapid growth. Recruiting new talent is paramount to our continued success.”

Asked about his 6-12 month goals, English noted, “Preparing the company to move into a new facility that will accommodate our growing organization, improve synergy with our manufacturing unit, and create a world-class training environment for our physicians and distributors.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy